Related Experiment Videos
The significance of beta-2 microglobulinuria associated with gentamicin therapy
Abstract:
Gentamicin is a nephrotoxic agent known to damage the proximal tubule,--a site of low molecular weight (LMW) protein reabsorption and catabolism. The effect of gentamicin was investigated on three LMW proteins--amylase, light chains, and beta 2 microglobulin--and the effects were correlated on the latter to renal function as determined by creatinine clearance (GFR). The renal excretion of beta 2 microglobulin (beta 2M) was studied in 18 patients receiving gentamicin and eight control patients. Both gentamicin and control patients had similar mean ages and serum beta 2M. Twelve of the 18 gentamicin treated patients had marked increases in beta 2M excretion. The mean daily 2 beta microglobulin excretion for the gentamicin treated group was 10,511 microgram while that of the control group was 102 microgram. Serial determinations in 10 of the gentamicin treated patients revealed an increase in beta 2M excretion within 48 hours of starting therapy. No deterioration of GFR was seen in any patient. In four patients, beta 2M excretion decreased while still receiving gentamicin. The renal handling of amylase was found to be normal in four patients and mildly abnormal in three patients receiving gentamicin who also had increased beta 2M excretion. Urinary light chains were determined in four of these seven patients and found to be normal. It is concluded that gentamicin induces an early and often transient tubular proteinuria. This tubular proteinuria is not associated with clinical nephrotoxicity.
Insights
Gentamicin causes early, temporary tubular proteinuria by affecting low molecular weight proteins like beta 2 microglobulin. This protein increase in urine does not indicate clinical kidney damage.
Area of Science:
- Nephrology
- Pharmacology
- Biochemistry
Background:
- Gentamicin is a known nephrotoxic antibiotic.
- Proximal tubules are crucial for reabsorbing and metabolizing low molecular weight (LMW) proteins.
- Gentamicin's impact on LMW protein handling by the kidneys requires further investigation.
Purpose of the Study:
- To investigate the effect of gentamicin on the renal excretion of specific LMW proteins: amylase, light chains, and beta 2 microglobulin (beta 2M).
- To correlate changes in beta 2M excretion with renal function, assessed by creatinine clearance (GFR).
Main Methods:
- Studied renal excretion of beta 2 microglobulin in 18 patients receiving gentamicin and 8 controls.
- Monitored serial beta 2M excretion in 10 gentamicin-treated patients.
- Assessed renal handling of amylase and urinary light chains in select patients.
Main Results:
- 12 of 18 gentamicin-treated patients showed marked increases in beta 2M excretion (mean 10,511 vs 102 microgram/day in controls).
- Increased beta 2M excretion was observed within 48 hours of gentamicin initiation.
- No deterioration in GFR was noted; beta 2M excretion sometimes decreased during continued gentamicin therapy.
- Renal handling of amylase was mostly normal, and light chains were normal in the studied patients.
Conclusions:
- Gentamicin induces an early, often transient, tubular proteinuria.
- This gentamicin-induced tubular proteinuria is characterized by increased beta 2 microglobulin excretion.
- The observed tubular proteinuria is not associated with clinical signs of nephrotoxicity.